Tecentriq 1 875 mg solution for injection

Active Ingredient
Strength
  • Atezolizumab: 1875 mg
Dosage Form
Solution for injection and concentrate for infusion
Legal Category
A - prescription, may not be renewed
Last Updated
25/09/2026
SPC section shown.

Loading the document

Roche Registration GmbH

3030 Lake Drive, Citywest Business Campus, Dublin 24, D24 KX6Y, Ireland